Search

Search Results
Results 501 - 510 of 518 for energy healing
  • Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Pariet (Rabeprazole sodium) intended for persons living in Australia.
  • Drug - 15 Nov 2022
    Consumer Medicine Information (CMI) about Osteovan (Zoledronic acid) intended for persons living in Australia.
  • Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
  • Drug - 3 Jun 2022
    Consumer Medicine Information (CMI) about Tinasil (Terbinafine) intended for persons living in Australia.
  • Health - 23 Dec 2021
    The immune system is a central difference in the protection against pathogenic organisms. This article looks at optimizing your immune system.
  • Drug - 22 Jan 2021
    Consumer Medicine Information (CMI) about Rabeprazole Mylan (rabeprazole sodium) intended for persons living in Australia.
  • Drug - 13 Feb 2020
    Consumer Medicine Information (CMI) about Lamisil Tablets (terbinafine) intended for persons living in Australia.
  • White Paper - 6 Sep 2018
    Bioabsorbable scaffolds may be considered the new threshold in endovascular treatment. The National Institutes of Health (NIH) report that the most frequent form of heart disease is coronary artery...
  • White Paper - 8 Sep 2017
    The aim of minimal invasive surgery (MIS), as the name suggests, is to cause minimal discomfort to patients. Here, endoscopes play a vital role. However, conventional Chip-on-the-Tip endoscopes that...
  • Drug - 3 Jul 2024
    Consumer Medicine Information (CMI) about Ibrance tablets intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.